Besides CA125, other significant prognostic factors included tumor size, lymph node positivity, high mitotic activity, vascular invasion, and high BMI, suggesting that the biomarker could be part of a multifactorial prognostic panel. The gene discussed is MUC16; the disease is neoplasm.